Hydroxylation of testosterone by bacterial cytochromes P450 using the Escherichia coli expression system. 2006

Hitosi Agematu, and Naoki Matsumoto, and Yoshikazu Fujii, and Hiroki Kabumoto, and Satoru Doi, and Kazuhiro Machida, and Jun Ishikawa, and Akira Arisawa
Bioresource Laboratories, Mercian Corp, Japan. agematsu-h@mercian.co.jp

Two hundred thirteen cytochrome P450 (P450) genes were collected from bacteria and expressed based on an Escherichia coli expression system to test their hydroxylation ability to testosterone. Twenty-four P450s stereoselectively monohydroxylated testosterone at the 2alpha-, 2beta-, 6beta-, 7beta-, 11beta-, 12beta-, 15beta-, 16alpha-, and 17-positions (17-hydroxylation yields 17-ketoproduct). The hydroxylation site usage of the P450s is not the same as that of human P450s, while the 2alpha-, 2beta-, 6beta-, 11beta-, 15beta-, 16alpha-, and 17-hydroxylation are reactions common to both human and bacterial P450s. Most of the testosterone hydroxylation catalyzed by bacterial P450s is on the beta face.

UI MeSH Term Description Entries
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D003577 Cytochrome P-450 Enzyme System A superfamily of hundreds of closely related HEMEPROTEINS found throughout the phylogenetic spectrum, from animals, plants, fungi, to bacteria. They include numerous complex monooxygenases (MIXED FUNCTION OXYGENASES). In animals, these P-450 enzymes serve two major functions: (1) biosynthesis of steroids, fatty acids, and bile acids; (2) metabolism of endogenous and a wide variety of exogenous substrates, such as toxins and drugs (BIOTRANSFORMATION). They are classified, according to their sequence similarities rather than functions, into CYP gene families (>40% homology) and subfamilies (>59% homology). For example, enzymes from the CYP1, CYP2, and CYP3 gene families are responsible for most drug metabolism. Cytochrome P-450,Cytochrome P-450 Enzyme,Cytochrome P-450-Dependent Monooxygenase,P-450 Enzyme,P450 Enzyme,CYP450 Family,CYP450 Superfamily,Cytochrome P-450 Enzymes,Cytochrome P-450 Families,Cytochrome P-450 Monooxygenase,Cytochrome P-450 Oxygenase,Cytochrome P-450 Superfamily,Cytochrome P450,Cytochrome P450 Superfamily,Cytochrome p450 Families,P-450 Enzymes,P450 Enzymes,Cytochrome P 450,Cytochrome P 450 Dependent Monooxygenase,Cytochrome P 450 Enzyme,Cytochrome P 450 Enzyme System,Cytochrome P 450 Enzymes,Cytochrome P 450 Families,Cytochrome P 450 Monooxygenase,Cytochrome P 450 Oxygenase,Cytochrome P 450 Superfamily,Enzyme, Cytochrome P-450,Enzyme, P-450,Enzyme, P450,Enzymes, Cytochrome P-450,Enzymes, P-450,Enzymes, P450,Monooxygenase, Cytochrome P-450,Monooxygenase, Cytochrome P-450-Dependent,P 450 Enzyme,P 450 Enzymes,P-450 Enzyme, Cytochrome,P-450 Enzymes, Cytochrome,Superfamily, CYP450,Superfamily, Cytochrome P-450,Superfamily, Cytochrome P450
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006900 Hydroxylation Placing of a hydroxyl group on a compound in a position where one did not exist before. (Stedman, 26th ed) Hydroxylations
D013739 Testosterone A potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL. 17-beta-Hydroxy-4-Androsten-3-one,17-beta-Hydroxy-8 alpha-4-Androsten-3-one,8-Isotestosterone,AndroGel,Androderm,Andropatch,Androtop,Histerone,Sterotate,Sustanon,Testim,Testoderm,Testolin,Testopel,Testosterone Sulfate,17 beta Hydroxy 4 Androsten 3 one,17 beta Hydroxy 8 alpha 4 Androsten 3 one,8 Isotestosterone
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D015964 Gene Expression Regulation, Bacterial Any of the processes by which cytoplasmic or intercellular factors influence the differential control of gene action in bacteria. Bacterial Gene Expression Regulation,Regulation of Gene Expression, Bacterial,Regulation, Gene Expression, Bacterial

Related Publications

Hitosi Agematu, and Naoki Matsumoto, and Yoshikazu Fujii, and Hiroki Kabumoto, and Satoru Doi, and Kazuhiro Machida, and Jun Ishikawa, and Akira Arisawa
June 2005, Drug metabolism and disposition: the biological fate of chemicals,
Hitosi Agematu, and Naoki Matsumoto, and Yoshikazu Fujii, and Hiroki Kabumoto, and Satoru Doi, and Kazuhiro Machida, and Jun Ishikawa, and Akira Arisawa
August 1997, Nature biotechnology,
Hitosi Agematu, and Naoki Matsumoto, and Yoshikazu Fujii, and Hiroki Kabumoto, and Satoru Doi, and Kazuhiro Machida, and Jun Ishikawa, and Akira Arisawa
June 2004, Biochimica et biophysica acta,
Hitosi Agematu, and Naoki Matsumoto, and Yoshikazu Fujii, and Hiroki Kabumoto, and Satoru Doi, and Kazuhiro Machida, and Jun Ishikawa, and Akira Arisawa
November 1994, Archives of biochemistry and biophysics,
Hitosi Agematu, and Naoki Matsumoto, and Yoshikazu Fujii, and Hiroki Kabumoto, and Satoru Doi, and Kazuhiro Machida, and Jun Ishikawa, and Akira Arisawa
September 2015, Journal of bioscience and bioengineering,
Hitosi Agematu, and Naoki Matsumoto, and Yoshikazu Fujii, and Hiroki Kabumoto, and Satoru Doi, and Kazuhiro Machida, and Jun Ishikawa, and Akira Arisawa
October 1997, Archives of biochemistry and biophysics,
Hitosi Agematu, and Naoki Matsumoto, and Yoshikazu Fujii, and Hiroki Kabumoto, and Satoru Doi, and Kazuhiro Machida, and Jun Ishikawa, and Akira Arisawa
May 2015, Drug metabolism reviews,
Hitosi Agematu, and Naoki Matsumoto, and Yoshikazu Fujii, and Hiroki Kabumoto, and Satoru Doi, and Kazuhiro Machida, and Jun Ishikawa, and Akira Arisawa
January 2023, Frontiers in bioengineering and biotechnology,
Hitosi Agematu, and Naoki Matsumoto, and Yoshikazu Fujii, and Hiroki Kabumoto, and Satoru Doi, and Kazuhiro Machida, and Jun Ishikawa, and Akira Arisawa
January 1998, Methods in molecular biology (Clifton, N.J.),
Hitosi Agematu, and Naoki Matsumoto, and Yoshikazu Fujii, and Hiroki Kabumoto, and Satoru Doi, and Kazuhiro Machida, and Jun Ishikawa, and Akira Arisawa
January 1993, Journal of lipid mediators,
Copied contents to your clipboard!